Jack Tobin was named Chief Financial Officer of Cme Group Inc. As of November 6, 2026, Cme Group Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from June 17, 2026 to September 9, 2026, naming 2 appointments (Form 8-K, September 9, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Cme Group Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Cme Group Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-06-17 to 2026-09-09. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Cme Group Inc. files it.
Also on the record for Cme Group Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.45% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 5, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 10.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Cme Group Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Cme Group Inc. and the records around it.
Cme Group Inc. elsewhere on the record
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Cme Group Inc.
Get an email when Cme Group Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cme Group Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cme Group Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cme Group Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-09 | In | Chief Financial Officer | 8-K, 2026-09-09 | ||
| 2026-06-17 | In | Chief Executive Officer | 8-K, 2026-06-17 |
Who leads Cme Group Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Jack Tobin, appointed (filed 2026-09-09).
- Chief Executive Officer: Terrence A. Duffy, appointed (filed 2026-06-17).
New leaders reset buying decisions — get the Full Report on Cme Group Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Cme Group Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Cme Group Inc.Every change, in the filing's words
Appointed: Jack Tobin, Chief Financial Officer
Jack Tobin, 63, will be appointed to the role of Managing Director, Deputy Chief Financial Officer as of November 2, 2026.
- As described in the attached press release, CME Group Inc. ("CME Group" or the "Company") announced new senior leadership appointments in its finance and legal divisions.
- Mr. Tobin has served as Managing Director and Chief Accounting Officer since 2015.
- He most recently served as Managing Director, Corporate Finance since 2007.
- Prior to our merger with CBOT Holdings, Mr. Tobin served as the Director, Corporate Finance for CBOT Holdings and CBOT from 2002 to 2007.
- Prior to joining CBOT, Mr. Tobin served as a principal consultant with PricewaterhouseCoopers from 1997 to 2002.
- Mr. Tobin is a registered certified public accountant.
- As the Senior Managing Director, Chief Financial Officer, Mr. Tobin will be a member of the Company's Management Team.
- Matthew Render, 47, will succeed Mr. Tobin as the Company's Managing Director, Chief Accounting Officer effective as of November 2, 2026.
- Mr. Render joined CME Group as the Managing Director, Deputy Chief Accounting Officer in August 2026.
- Prior to joining CME Group, Mr. Render was the Global Head of Financial Reporting, Accounting Policy & Finance Transformation at Citadel and Citadel Securities since 2018.
Appointed: Terrence A. Duffy, Chief Executive Officer
Chief Executive Officer Leadership Transition On June 17, 2026, CME Group Inc. (the "Company") announced that Terrence A. Duffy, the Company's current Chairman and Chief Executive Officer, will become the Company's Executive Chairman, and Lynne C. Fitzpatrick, the Company's current President and Chief Financial Officer, will succeed Mr. Duffy as the Company's Chief Executive Officer (the "Leadership Transition").
- The Leadership Transition was approved by the Board of Directors on June 16, 2026 and will become effective on the later of March 1, 2027, and the date on which the Company files its Annual Report on Form 10-K with respect to 2026 (the "Transition Date").
- Mr. Duffy will continue to serve as the Company's Chief Executive Officer through the Transition Date and will then serve as the Company's Executive Chairman from the Transition Date through December 31, 2027.
- Ms. Fitzpatrick will continue to serve as the Company's President and Chief Financial Officer through the Transition Date and will then assume the role of Chief Executive Officer and be appointed to the Board and its Executive Committee on the Transition Date.
- The Company will initiate a search of potential candidates for a successor to Ms. Fitzpatrick as the Company's Chief Financial Officer.
- Ms. Fitzpatrick, age 48, has served as the Company's President and Chief Financial Officer since November 2024, when her role expanded to oversee human resources and transformation and execution, as well as her prior responsibilities for overseeing the Company's finance functions.
- She previously served as Chief Financial Officer since April 2023, Deputy Chief Financial Officer since 2022 and Managing Director of Corporate Development and Treasurer of the Company since 2017.
Tools for this story
Each opens in a new tab, filled in for Cme Group Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.